Inventaire - your friends and communities are your best library

Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: a cross-sectional study

автор

Angela. E. Taylor

Anthony Fenton

Rowan Hardy

Wiebke Arlt

опубликовано в: Clinical Endocrinology

дата публикации: 2018-11-15

язык: английский язык

главная тема: Хроническая болезнь почек

Cites articles 45

Дата

Заголовок

Авторы

2017-03-29

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials

Sophia Zoungas, Hertzel C. Gerstein, Rury Holman, John Chalmers, Hisatomi Arima, Peter D Reaven, Ruth L Coleman
2016-04-07

Changes in gluconeogenesis and intracellular lipid accumulation characterize uremic human hepatocytes ex vivo.

Ewa C Ellis, Meng Li, Helene Johansson, Davide Gnocchi
2016-08-31

11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation

Rowan Hardy, Paul Stewart, Mary O'Leary, Craig L Doig, Mark J Pearson, Simon W. Jones, Amy Naylor, Christopher D Buckley
2016-10-05

Insulin resistance in chronic kidney disease: a systematic review
2016-10-07

Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity.

Harald Staiger, Norbert Stefan, Hans-Ulrich Häring, Jürgen Machann, Fritz Schick, Andreas Fritsche, Fausto Machicao, Konstantinos Kantartzis, Apostolia Lamprinou, Ingmar Königsrainer, Alfred Königsrainer
2015-04-01

Comorbidities in Cushing's disease

Richard A Feelders, Lynnette K Nieman, Susmeeta T Sharma
2015-05-14

Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis

Paul Stewart, Rowan Hardy, Jeremy W Tomlinson, Christopher D Buckley
2014-01-02

TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritis

Iain McInnes, Christopher D Buckley
2014-02-25

Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia

Petros Andrikopoulos, Scott P Webster
2014-04-17

Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls.

Alessandra Munarini, Ruth Andrew
2014-06-02

11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess

Paul Stewart, Jeremy W Tomlinson
2013-01-29

Kidney disease and increased mortality risk in type 2 diabetes

Michael C Sachs, Bryan R Kestenbaum, Jonathan Himmelfarb, Ian H de Boer, Maryam Afkarian
2013-04-25

The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol

Praveen Sharma, Thomas Dietrich, Charles J. Ferro, Paul Cockwell, Iain Chapple
2013-07-01

11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action
2012-07-01

Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells

Andrew R. Clark, Paul Stewart, Christopher M. Jones, Cecile Bénézech, Rowan Hardy, Christopher D Buckley, Martin Hewison
2012-03-01

Chronic kidney disease, insulin resistance, and incident diabetes in older adults

Cassianne Robinson-Cohen, David S Siscovick, Joachim H. Ix, Bryan R Kestenbaum
2012-08-07

Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).
2012-08-07

Insulin resistance in patients with chronic kidney disease
2012-09-27

Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

CRIC Study Investigators, Matthias Girndt, Muredach P. Reilly
2011-06-01

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.
2011-02-15

Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1.

Paul Stewart, Alexander J. Lawson, Wiebke Arlt
2011-06-22

Can 11β-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease?

Jon H Tobias
2011-09-14

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

Giuseppe Opocher, Wiebke Arlt, Michael Biehl, Angela. E. Taylor, Stefanie Hahner, Rossella Libé, David J Smith, Nils Krone, Jérome Bertherat, Massimo Terzolo
2010-04-22

The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy

Julio Rosenstock, Silvio E Inzucchi
2010-11-01

The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease

Paul Stewart, Charles J. Ferro, Jonathan N Townend, Richard P Steeds
2009-08-12

11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle

Paul Stewart, Jeremy W Tomlinson, Jaswinder K. Sethi
2008-01-01

Inflammation and insulin resistance in uremia
2008-04-17

Local and systemic glucocorticoid metabolism in inflammatory arthritis

Paul Emery, Rowan Hardy, Christopher D Buckley
2008-04-03

Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients
2008-10-31

Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases
2007-11-06

Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor

Paul Stewart
2006-02-01

Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome

Simon Wessely

Статья - wd:Q57785193

Добро пожаловать в Inventaire

the library of your friends and communities

узнать больше